Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Biosimilars Deals 2023
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Trade Marks

Dr Reddy’s Biologics Facility Receives Further Form 483 Objections Following US FDA Inspection

Oct 28, 2023

Dr Reddy’s informed the Indian National Stock exchange on 28 October 2023 that the FDA issued a Form 483 with ten observations for Dr Reddy’s biologics manufacturing facility in Hyderabad.  The observations were issued as part of a routine cGMP inspection of the facility by the FDA between 19 and 27 October 2023.  Dr Reddy’s confirmed in the announcement that it will address all ten observations within the stipulated timeline.

On 12 October 2023, the FDA issued a Form 483 with nine observations regarding that same Dr Reddy’s biologics manufacturing facility, after a product-specific pre-approval inspection by the FDA between 4 and 12 October.